- Home
- FBIOP vs PPTA Comparison
FBIOP vs PPTA Comparison
Compare FBIOP & PPTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBIOP
- PPTA
- Stock Information
- Founded
- FBIOP N/A
- PPTA 2011
- Country
- FBIOP United States
- PPTA United States
- Employees
- FBIOP 101
- PPTA N/A
- Industry
- FBIOP Biotechnology: Pharmaceutical Preparations
- PPTA Precious Metals
- Sector
- FBIOP Health Care
- PPTA Basic Materials
- Exchange
- FBIOP Nasdaq
- PPTA Nasdaq
- Market Cap
- FBIOP N/A
- PPTA N/A
- IPO Year
- FBIOP N/A
- PPTA N/A
- Fundamental
- Price
- FBIOP $8.41
- PPTA $14.83
- Analyst Decision
- FBIOP
- PPTA Strong Buy
- Analyst Count
- FBIOP 0
- PPTA 3
- Target Price
- FBIOP N/A
- PPTA $21.17
- AVG Volume (30 Days)
- FBIOP N/A
- PPTA 4.6M
- Earning Date
- FBIOP N/A
- PPTA 08-08-2025
- Dividend Yield
- FBIOP N/A
- PPTA N/A
- EPS Growth
- FBIOP N/A
- PPTA N/A
- EPS
- FBIOP N/A
- PPTA N/A
- Revenue
- FBIOP N/A
- PPTA N/A
- Revenue This Year
- FBIOP N/A
- PPTA N/A
- Revenue Next Year
- FBIOP N/A
- PPTA N/A
- P/E Ratio
- FBIOP N/A
- PPTA N/A
- Revenue Growth
- FBIOP N/A
- PPTA N/A
- 52 Week Low
- FBIOP N/A
- PPTA $5.25
- 52 Week High
- FBIOP N/A
- PPTA $17.96
- Technical
- Relative Strength Index (RSI)
- FBIOP 56.06
- PPTA 60.58
- Support Level
- FBIOP $7.82
- PPTA $12.20
- Resistance Level
- FBIOP $8.60
- PPTA $14.95
- Average True Range (ATR)
- FBIOP 0.45
- PPTA 0.86
- MACD
- FBIOP -0.01
- PPTA 0.23
- Stochastic Oscillator
- FBIOP 80.73
- PPTA 96.33
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.